Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-142046
Filing Date
2025-06-17
Accepted
2025-06-17 16:05:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7287
  Complete submission text file 0001193125-25-142046.txt   8255
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)